Lerzeparib
Lerzeparib is an (ADP-ribose) polymerase (PARP) inhibitor, with antineoplastic activity[1].
Product Specifications
CAS Number
2459693-01-5
UNSPSC
12352005
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lerzeparib.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C3C(CON1)=C(C4=CC=C([C@]5(CCCN5)C)C=C4)NC3=CC(F)=C2
Molecular Formula
C21H20FN3O2
Molecular Weight
365.40
References & Citations
[1]Hu Yanbin, et al. Indolo heptamyl oxime analogue as PARP inhibitor. World Intellectual Property Organization, WO2020156577 A1. 2020-08-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog